“he's seeing dramatic results (not clinical) in
Post# of 148179
My hope is that since these patients are in the mild to moderate category, that their immunologic response correlates with clinical evidence of the same. The same immunologic responses were seen in the first 11 EIND patients but unfortunately many of those patients were too sick and too far along in the COVID19 illness to experience clinical benefit. Mid to end June will be very exciting if the trial fully enrolls by the end of May.